Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes.

Comparison of gene expressing profiles between gliomas with different grades revealed frequent overexpression of insulin-like growth factor binding protein 2 (IGFBP2) in glioblastoma (GBM), the most advanced stage of glioma. To determine whether IGFBP2 is involved in the proliferative and invasive nature of GBM, we established stable SNB19 GBM cell lines that overexpress IGFBP2. Although there was no marked difference in the cell growth between IGFBP2 overexpressing SNB19(BP2) lines when compared with the control cells, these clones showed significantly increased invasive rates when compared with the parental or vector transfected SNB19 cells. Total RNAs from controls and SNB19(BP2) clones were used for microarray analysis to detect IGFBP2-mediated alterations in gene expression. When compared with parental or vector-transfected control cells, SNB19(BP2) cells consistently showed 3-5-fold increase in the expression of matrix metalloproteinase-2 (MMP-2) as well as other invasion related genes. Increased MMP-2 expression in SNB19(BP2) cells was subsequently confirmed by real time reverse-transcription PCR, Western blotting, and gelatin zymography. Furthermore, consistent with increased MMP-2 expression in SNB19(BP2) cells, transient transfection of a MMP-2 promoter/luciferase reporter also resulted in 3-6-fold higher luciferase activity in SNB19(BP2) cells than in parental or vector-transfected control cells. Finally, tissue microarray analysis of 68 GBM tissue specimens showed a significant correlation between the overexpression of IGFBP2 and elevated MMP-2 expression. Taken together, our data provide evidence that IGFBP2 contributes to glioma progression in part by enhancing MMP-2 gene transcription and in turn tumor cell invasion.

[1]  P. Anthony.  Robbins' Pathologic Basis of Disease , 1990 .

[2]  T. Wood,et al.  Expression of the IGFBP-2 gene in post-implantation rat embryos. , 1992, Development.

[3]  D. Leavesley,et al.  Requirement of the integrin beta 3 subunit for carcinoma cell spreading or migration on vitronectin and fibrinogen , 1992, The Journal of cell biology.

[4]  P. Brodal.  The Central Nervous System , 1992 .

[5]  Serum and plasma M(r) 92,000 progelatinase levels correlate with spontaneous metastasis of rat 13762NF mammary adenocarcinoma. , 1993, Cancer research.

[6]  N. Bleehen,et al.  Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors. , 1993, Cancer research.

[7]  C. Bondy,et al.  Localization of insulin-like growth factor binding protein-2 messenger RNA during postnatal brain development: Correlation with insulin-like growth factors I and II , 1993, Neuroscience.

[8]  M. Papa,et al.  Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: correlation with serum prostate-specific antigen. , 1993, The Journal of clinical endocrinology and metabolism.

[9]  T. Wood,et al.  Tissue-specific expression of the insulin-like growth factor binding protein (IGFBP) mRNAs in mouse and rat development , 1993, Regulatory Peptides.

[10]  D. Rifkin,et al.  Biology and biochemistry of proteinases in tumor invasion. , 1993, Physiological reviews.

[11]  W. Blum,et al.  Insulin-like growth factor-binding protein-2 concentrations in cerebrospinal fluid and serum of children with malignant solid tumors or acute leukemia. , 1994, The Journal of clinical endocrinology and metabolism.

[12]  Z. Shao,et al.  Insulin‐like growth factor‐binding protein enhancement of insulin‐like growth factor‐i (IGF‐I)–mediated DNA synthesis and IGF‐I binding in a human breast carcinoma cell line , 1994, Journal of cellular physiology.

[13]  E. Feldman,et al.  Immunohistochemical localization of insulin-like growth factor-II (IGF-II) and IGF-binding protein-2 during development in the rat brain. , 1994, Endocrinology.

[14]  T. Wood,et al.  Distinct expression patterns of insulin-like growth factor binding proteins 2 and 5 during fetal and postnatal development. , 1994, Endocrinology.

[15]  Y. Sun,et al.  Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter , 1997, Molecular and cellular biology.

[16]  Elevated serum insulin-like growth factor-binding protein 2 (IGFBP-2) and decreased IGFBP-3 in epithelial ovarian cancer: correlation with cancer antigen 125 and tumor-associated trypsin inhibitor. , 1997, The Journal of clinical endocrinology and metabolism.

[17]  G. Werther,et al.  The Role of the Insulin-Like Growth Factor System in the Developing Brain , 1998, Hormone Research in Paediatrics.

[18]  M. Binoux,et al.  IGFBP‐2 expression in a human cell line is associated with increased IGFBP‐3 proteolysis, decreased IGFBP‐1 expression and increased tumorigenicity , 1998, International journal of cancer.

[19]  P. Brodt,et al.  Regulation of the Mr 72,000 type IV collagenase by the type I insulin-like growth factor receptor. , 1998, Cancer research.

[20]  T. Mikkelsen,et al.  Increased SPARC expression promotes U87 glioblastoma invasion in vitro , 1999, International Journal of Developmental Neuroscience.

[21]  W. Yung,et al.  Reactivation of insulin-like growth factor binding protein 2 expression in glioblastoma multiforme: a revelation by parallel gene expression profiling. , 1999, Cancer research.

[22]  O. Bernard,et al.  Interactions between bcl-2 and the IGF system control apoptosis in the developing mouse brain. , 1999, Brain research. Developmental brain research.

[23]  Y. Kodera,et al.  Rapid quantitative detection of carcinoembryonic antigen–expressing free tumor cells in the peritoneal cavity of gastric‐cancer patients with real‐time RT‐PCR on the lightcycler , 2000, International journal of cancer.

[24]  D. Flint,et al.  Altered expression of insulin-like growth factor -1 and insulin like growth factor binding proteins-2 and 5 in the mouse mutant Hypodactyly (Hd) correlates with sites of apoptotic activity , 2000, Anatomy and Embryology.

[25]  A. Hoeflich,et al.  Overexpression of insulin-like growth factor-binding protein-2 results in increased tumorigenic potential in Y-1 adrenocortical tumor cells. , 2000, Cancer research.

[26]  O. Kallioniemi,et al.  Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques. , 2000, Cancer research.

[27]  R. Baxter,et al.  Nuclear Import of Insulin-like Growth Factor-binding Protein-3 and -5 Is Mediated by the Importin β Subunit* , 2000, The Journal of Biological Chemistry.

[28]  Kevin R. Coombes,et al.  Identifying Differentially Expressed Genes in cDNA Microarray Experiments , 2001, J. Comput. Biol..

[29]  Frank Duffner,et al.  In VivoExpression of Insulin-Like Growth Factor-Binding Protein-2 in Human Gliomas Increases with the Tumor Grade. , 2001, Endocrinology.

[30]  G. Fuller,et al.  Insulin‐like Growth Factor Binding Protein 2: Gene Expression Microarrays and the Hypothesis‐generation Paradigm , 2002, Brain pathology.

[31]  Ilya Shmulevich,et al.  Binary analysis and optimization-based normalization of gene expression data , 2002, Bioinform..

[32]  Wei Zhang,et al.  Obtaining reliable information from minute amounts of RNA using cDNA microarrays , 2002, BMC Genomics.

[33]  Wei Zhang,et al.  Tissue Microarrays: Applications in Neuropathology Research, Diagnosis, and Education , 2002, Brain pathology.

[34]  R. Hurta,et al.  Insulin like growth factor-1 selectively regulates the expression of matrix metalloproteinase-2 in malignant H-ras transformed cells , 2001, Molecular and Cellular Biochemistry.

[35]  Y. Kanemura,et al.  Role of fibronectin-stimulated tumor cell migration in glioma invasion in vivo: clinical significance of fibronectin and fibronectin receptor expressed in human glioma tissues , 1998, Clinical & Experimental Metastasis.

[36]  G. Sutherland,et al.  High levels of gelatinase-B and active gelatinase-A in metastatic glioblastoma , 2004, Journal of Neuro-Oncology.

[37]  G. Fuller,et al.  Expression and localization of 72 kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo , 2004, Clinical and Experimental Metastasis.